Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Adaptive Biotechnologies Corp shares valued at $1,574,237 were sold by ROBINS CHAD M on Feb 19 ’25. At $8.46 per share, ROBINS CHAD M sold 186,080 shares. The insider’s holdings dropped to 2,576,701 shares worth approximately $20.69 million following the completion of this transaction.
Also, ROBINS CHAD M sold 99,107 shares, netting a total of over 836,463 in proceeds. Following the sale of shares at $8.44 each, the insider now holds 2,576,701 shares.
Before that, Chad Robins had added 99,107 shares to its account. In a trade valued at $829,526, the Officer bought Adaptive Biotechnologies Corp shares for $8.37 each.
Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in early January. As of December 21, 2022, Piper Sandler has increased its “Neutral” rating to a “an Overweight” for ADPT. Earlier on August 25, 2022, Credit Suisse initiated its rating. Their recommendation was “an Underperform” for ADPT stock.
Analyzing ADPT Stock Performance
During the last five days, there has been a drop of approximately -3.95%. Over the course of the year, Adaptive Biotechnologies Corp shares have jumped approximately 33.94%. Shares of the company reached a 52-week high of $8.95 on 02/18/25 and a 52-week low of $5.96 on 01/02/25. A 50-day SMA is recorded $7.45, while a 200-day SMA reached $5.29.
Support And Resistance Levels for Adaptive Biotechnologies Corp (ADPT)
According to the 24-hour chart, there is a support level at 7.05, which, if violated, would cause prices to drop to 6.07. In the upper region, resistance lies at 8.75. The next price resistance is at 9.47. RSI (Relative Strength Index) is 51.84 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.20, which suggests the price will decrease in the coming days. Percent R is at 42.59%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
